
Terray Therapeutics is an AI-powered biotechnology company focused on revolutionizing small molecule drug discovery. Their platform, tNova, uniquely integrates high-throughput chemical…

Terray Therapeutics is an AI-powered biotechnology company focused on revolutionizing small molecule drug discovery. Their platform, tNova, uniquely integrates high-throughput chemical…
What they do: AI-powered, chemistry-first platform (tNova / EMMI) for small-molecule drug discovery combining high-throughput experimental chemistry and generative AI
Data scale: Experimental dataset of over two billion target–ligand binding measurements, growing rapidly
Funding: Raised >$200M total; $120M Series B announced Oct 17, 2024
Focus areas: Internal immunology programs and partnered programs with large pharma
Small-molecule drug discovery, particularly challenging targets in immunology and partnered pharma programs.
2018
Biotechnology Research
120000000
Announced as an oversubscribed round; brought total equity financing to over $200M.
60000000
20000000
“Syndicate includes institutional and strategic investors (e.g., Bedford Ridge Capital, NVentures/NVIDIA, Madrona, Two Sigma Ventures, Digitalis Ventures, XTX Ventures, Goldcrest Capital, Alexandria Venture Investments)”
Company Overview: Terray Therapeutics is a venture-backed biotechnology company led by pioneers and long-time leaders in artificial intelligence, synthetic chemistry, automation, and nanotechnology. We’re generating chemical data purpose-built to propel drug discovery into the information age — and we’re doing it on a larger scale and faster than has ever before been possible.
Our closed loop system generates precise chemical datasets at unrivaled scale that work seamlessly with AI to systematically map biochemical interactions between small molecules and causes of disease. Iterative cycles of virtual molecular design and experimentation power AI and machine learning models, which in turn guide the next cycle of design. With a chemistry engine that measures billions of interactions daily and becomes increasingly precise with every cycle, we can answer an unprecedented array of questions — deriving insights that enable us to predictably create drugs for patients in need.
Terray Therapeutics is seeking a motivated, creative, and experienced Associate Automation Engineer. As an integral member of our Automation team, the candidate will be responsible for implementing and maintaining the automated systems that power our wet-lab. The position will report to the laboratory automation lead responsible for microscope support and development.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,500+
New This Week
| Company |
|---|
The Core Responsibilities Of This Position Are
Experience and Qualifications: Given the company’s size, anticipated growth, and fast-paced environment, the organization requires an automation engineer who is thoughtful, high-energy, and can partner with the broader organization to further enhance our next-generation drug discovery capabilities.
Part of Terray Therapeutics’ success is nurtured by a hands-on work environment where everyone is accountable, everyone is vested in a vision of excellence, and everyone actively takes part in the success of the business. Terray Therapeutics supports a positive work environment comprised of engaged employees who feel appreciated, recognized, and free to be creative.
Preferred Qualifications
Candidates will need the ability to work well under pressure to provide results in a short timeframe. The company is looking for a highly responsive, goal-oriented individual who will bring significant energy and drive to solve complex technical problems and help us achieve our mission to advance human health.
Compensation Details: $85,000 to $122,000 (annually) depending on experience; participation in the Company's option plan; 3% retirement safe harbor contribution; fully-paid medical, dental, vision, life, and disability benefits.